The future of precision therapy is here
Tzu Cancer Therapeutics is pioneering the development of precision therapies attacking metastatic cancer , the leading cause of cancer death.
We are inspired by the Chinese philospher Sun Tzu (544 - 596 BC), who wrote in the Art of War: “know your enemy and know yourself; in a hundred battles you will never be defeated.”
Our cancer therapies are based on in-depth knowledge of circulating tumor cells (CTCs), which cause metastasis and are the real enemy.
Our company
Our Approach
TzuPlus Platform
We established TzuPlus technology to get the deepest understanding of metastasizing cancer cells. TzuPlus maps the DNA, mRNA, and surface proteins for each individual circulating tumor cell.
Our clinically validated approach allows the screening of large blood volumes, recovering over up to 200 times more circulating tumor cells than conventional methods. A growing database of circulating tumor cell molecular information provides a gateway towards effective cancer precision therapy against metastatic disease.
Meet the team
Great science starts with great people. We are scientists, engineers, and thinkers who show up with curiosity, rigour, and a common purpose.
“Know the enemy and know yourself; in a hundred battles you will never be defeated”
— Sun Tzu (544 - 596 BC) - The Art of War
Our Partners
We are grateful to work alongside partners who share our commitment to precision, innovation, and impact.